During the past decade, Davide Perroni conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Davide Perroni" are "Advanced Prostate Cancer" (1 trials) and "Neuroendocrine Tumors" (1 trials). Many other conditions were trialed in "Davide Perroni" in a lesser frequency.

Most popular intervention types in "Davide Perroni" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Continuous Docetaxel" (1 trials), "Docetaxel" (1 trials), "Docetaxel + LH-RH analogues" (1 trials) and "continuous 5 fluouracil infusion plus long-acting octreotide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Davide Perroni" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Davide Perroni". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Davide Perroni, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Davide Perroni, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".